Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R.
Saved in:
| Title: | Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R. |
|---|---|
| Authors: | Meyer-Wentrup F; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Jonas SF; Biostatistics and Epidemiology Office, Gustave Roussy, INSERM U1018 Oncostat, Labelled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France., Knoerr F; Pediatric Hematology and Oncology and NHL-BFM Study Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Auperin A; Biostatistics and Epidemiology Office, Gustave Roussy, INSERM U1018 Oncostat, Labelled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France., Alexander S; Division of Hematology/Oncology/Bone Marrow Transplantation, BC Children's Hospital, The University of British Columbia, Vancouver, Canada., Andres M; Department of Pediatric Hematology and Oncology, University Hospital La Fe of Valencia, Valencia, Spain., Attarbaschi A; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.; Department of Pedatric Hematology and Oncology, St. Anna Children's Cancer Research Institute, Vienna, Austria., Burke GAA; Cancer Research UK Clinical Trials Unit, School of Medical Sciences, The University of Birmingham, Birmingham, United Kingdom., Burkhardt B; Department of Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany., Ceppi F; Pediatric Hematology-Oncology Unit, Division of Pediatrics, Department of Woman-Mother-Child, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland., Gross T; Department of Pediatric Hematology and Oncology, Phoenix Children's Hospital, Phoenix, AZ., Kabickova E; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic., Klapper W; Department of Hematopathology, University Medical Center Kiel, Kiel, Germany., Miles RR; Department of Pathology, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Taj M; Department of Pediatrics, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Zimmermann M; Department of Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany., Minard-Colin V; Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Woessmann W; Pediatric Hematology and Oncology and NHL-BFM Study Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. |
| Source: | Blood advances [Blood Adv] 2026 Jun 23; Vol. 10 (12), pp. 4370-4374. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41979343 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Meyer-Wentrup+F%22">Meyer-Wentrup F</searchLink>; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jonas+SF%22">Jonas SF</searchLink>; Biostatistics and Epidemiology Office, Gustave Roussy, INSERM U1018 Oncostat, Labelled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Knoerr+F%22">Knoerr F</searchLink>; Pediatric Hematology and Oncology and NHL-BFM Study Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Auperin+A%22">Auperin A</searchLink>; Biostatistics and Epidemiology Office, Gustave Roussy, INSERM U1018 Oncostat, Labelled Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Alexander+S%22">Alexander S</searchLink>; Division of Hematology/Oncology/Bone Marrow Transplantation, BC Children's Hospital, The University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Andres+M%22">Andres M</searchLink>; Department of Pediatric Hematology and Oncology, University Hospital La Fe of Valencia, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Attarbaschi+A%22">Attarbaschi A</searchLink>; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.; Department of Pedatric Hematology and Oncology, St. Anna Children's Cancer Research Institute, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Burke+GAA%22">Burke GAA</searchLink>; Cancer Research UK Clinical Trials Unit, School of Medical Sciences, The University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Burkhardt+B%22">Burkhardt B</searchLink>; Department of Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany.<br /><searchLink fieldCode="AU" term="%22Ceppi+F%22">Ceppi F</searchLink>; Pediatric Hematology-Oncology Unit, Division of Pediatrics, Department of Woman-Mother-Child, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gross+T%22">Gross T</searchLink>; Department of Pediatric Hematology and Oncology, Phoenix Children's Hospital, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Kabickova+E%22">Kabickova E</searchLink>; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Klapper+W%22">Klapper W</searchLink>; Department of Hematopathology, University Medical Center Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Miles+RR%22">Miles RR</searchLink>; Department of Pathology, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Taj+M%22">Taj M</searchLink>; Department of Pediatrics, The Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Zimmermann+M%22">Zimmermann M</searchLink>; Department of Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Minard-Colin+V%22">Minard-Colin V</searchLink>; Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Woessmann+W%22">Woessmann W</searchLink>; Pediatric Hematology and Oncology and NHL-BFM Study Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Jun 23; Vol. 10 (12), pp. 4370-4374. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41979343 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2025019553 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4370 Titles: – TitleFull: Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Meyer-Wentrup F – PersonEntity: Name: NameFull: Jonas SF – PersonEntity: Name: NameFull: Knoerr F – PersonEntity: Name: NameFull: Auperin A – PersonEntity: Name: NameFull: Alexander S – PersonEntity: Name: NameFull: Andres M – PersonEntity: Name: NameFull: Attarbaschi A – PersonEntity: Name: NameFull: Burke GAA – PersonEntity: Name: NameFull: Burkhardt B – PersonEntity: Name: NameFull: Ceppi F – PersonEntity: Name: NameFull: Gross T – PersonEntity: Name: NameFull: Kabickova E – PersonEntity: Name: NameFull: Klapper W – PersonEntity: Name: NameFull: Miles RR – PersonEntity: Name: NameFull: Taj M – PersonEntity: Name: NameFull: Zimmermann M – PersonEntity: Name: NameFull: Minard-Colin V – PersonEntity: Name: NameFull: Woessmann W IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 06 Text: 2026 Jun 23 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 10 – Type: issue Value: 12 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |